Impact of p53 and PDGFR-β Expression on Metastasis and Prognosis of Patients with Pancreatic Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of p53 and PDGFR-β Expression on Metastasis and Prognosis of Patients with Pancreatic Cancer

Published:2016-03-03 Issue:8 Volume:40 Page:1977-1984
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Kurahara Hiroshi,Maemura Kosei,Mataki Yuko,Sakoda Masahiko,Shinchi Hiroyuki,Natsugoe Shoji

Funder

Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-016-3477-2.pdf

Reference31 articles.

1. Vincent A, Herman J, Schulick R et al (2011) Pancreatic cancer. Lancet 378:607–620

2. Ying JE, Zhu LM, Liu BX (2012) Developments in metastatic pancreatic cancer: is gemcitabine still the standard? World J Gastroenterol 18:736–745

3. Cameron JL, Riall TS, Coleman J et al (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10–15

4. Yachida S, Iacobuzio-Donahue CA (2009) The pathology and genetics of metastatic pancreatic cancer. Arch Pathol Lab Med 133:413–422

5. Rose JB, Rocha FG, Alseidi A et al (2014) Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival. Ann Surg Oncol 21:1530–1537

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary cilia-associated signalling in squamous cell carcinoma of head and neck region;Frontiers in Oncology;2024-08-21

2. Functional and clinical roles of stromal PDGF receptors in tumor biology;Cancer and Metastasis Reviews;2024-07-09

3. Epigenetic control of pancreatic cancer metastasis;Cancer and Metastasis Reviews;2023-09-02

4. Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy;International Journal of Clinical Oncology;2023-08-18

5. A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation;mAbs;2023-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3